Health
Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients – Healio
An off-the-shelf, virus-specific T-cell therapy demonstrated proof of concept to enter a clinical trial for the treatment of severe COVID-19 infection, according…
Source/Disclosures
Source: Vasileiou S, et al. Abstract 612. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Vasileiou reports a consultant role with and research funding from AlloVir. Please see the abstract for all other researchers’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
An off-the-shelf, virus-specific…
-
Noosa News15 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General16 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General13 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
Noosa News16 hours agoThe Best Things to Do in Brisbane This New Year’s Eve